Health

640 stories · page 18 of 43

HealthEvidence-backed problem

A Real-World Evaluation of Large Language Model-Generated Hospital Courses in Pediatrics

Background Large language model (LLM)-generated hospital courses are increasingly integrated into electronic health records (EHRs), yet their accuracy and safety in pediatric populations remain poorly characterized. Objective To evaluate the accuracy, text quality, and perceived potential harm of EHR-integrated and LLM-generated hospital courses in pediatric inpatient care during early clinical implementation. Methods We conducted a descriptive evaluation from June 10 to August 8, 2025, at an academic freestandi…

Hospital Pediatrics

Evidence-backed problem

Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation

Evidence-backed gain

Development of a Machine Learning Algorithm for Differential Diagnosis Between Primary Immune Thrombocytopenia and Connective Tissue Disease-Related Thrombocytopenia in Pediatric Patients

Evidence-backed problem

Machine learning models for early detection of urinary tract infections in kidney transplant patients

Evidence-backed problem

SlideChat is a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types

Multimodal artificial intelligence, albeit showing great potential in computational pathology, remains limited to isolated patch-level interpretation and often fails to analyze gigapixel-scale whole-slide images (WSIs) essential for clinical utility. Here we present SlideChat, a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types. SlideChat integrates patch-level and slide-level pathology encoders with a pretrained large language model. Using 274,23…

Evidence-backed problem

Ethical Considerations on Artificial Intelligence, Health and Health Care. All That Glisters Is Not Gold

Background Artificial intelligence (AI) is transforming global health care through innovations in deep learning, generative models and agentic AI systems. Traditional reductionist approaches to complex pathophysiological pathways fail to capture the true complexity of disease, motivating the adoption of network medicine (NM), which models biological systems as dynamic, interconnected networks. When combined with AI, NM enables integration of multiomic data and better characterizes disease mechanisms to guide pre…

Evidence-backed problem

Clinical Applications of Artificial Intelligence in Cardiac CT: From Coronary CT Angiography to CT-Derived Fractional Flow Reserve and Myocardial Perfusion Imaging

Artificial intelligence (AI) has rapidly transformed cardiac CT, extending its clinical utility from coronary CT angiography (CCTA) to CT myocardial perfusion imaging (CT-MPI). This review outlines the current advances in and future perspectives on AI-aided cardiac CT across anatomical, functional, and prognostic dimensions. In CCTA, AI can automate calcium scoring, vessel segmentation, and plaque characterization, markedly improving workflow efficiency and reproducibility. Deep-learning models can allow accurat…

Evidence-backed gain

A polyline searching-driven evolutionary AI for disease detection of medical imaging data

Objective. Accurate Ultrasound (US) prostate cancer (PCa) segmentation images hold significant value for organ interventional guidance and clinical disease diagnosis. However, this task still poses substantial challenges. The main obstacles include blurred or incomplete boundaries separating PCa from adjacent soft tissues, shadow artifacts inherent to ultrasound imaging, and drastic inter-patient variations in organ morphological shapes. Approach . To address these issues, our method introduces a novel coarse-to…

Health

Methodological Reporting Quality of Artificial Intelligence-Based Orthopedic Studies: A Literature Analysis

Objective We set out to examine how completely artificial intelligence (AI)-based orthopedic studies report their methods. Methods A PubMed search covering 2023-2025 was run with a predefined strategy. Screening of titles, abstracts and full texts left 280 eligible papers, and 200 of these were drawn at random for scoring. Each paper was rated against a six-item framework built from the TRIPOD-AI, STARD-AI and CONSORT-AI guidelines. Results Mean score across the 200 studies was 4.8±0.9. Twenty-eight percent reac…

Health

Post-traumatic Psychopathology and Cardiovascular Risk: A Danish Case-Control Study of Sex-Specific Associations

Background There is increasing recognition that trauma exposure and related psychiatric consequences predict cardiovascular disease risk. However, most research has specifically examined post-traumatic stress disorder-despite evidence that a range of psychiatric disorders may follow trauma. We applied machine learning to identify key post-traumatic psychiatric predictors of incident major adverse cardiac and cerebrovascular events (MACCE) in a population-based cohort. Methods We conducted a case-control study of…

Health

A strategic pathway for the ethical development of AI tools in dementia care

Artificial intelligence (AI) is rapidly entering dementia clinical practice, offering opportunities across the care continuum. However, cognitive decline creates a unique ethical challenge. This perspective article proposes a strategy to ensure the responsible development and deployment of AI tools for dementia. An interdisciplinary workgroup of the Alzheimer's Association Innovation Roundtable synthesized ethical frameworks, regulatory standards, and empirical evidence to generate expert consensus. The result i…

Health

Artificial intelligence-assisted histopathological diagnosis of endocervical gastric-type adenocarcinoma: a multicenter model development and validation study

Endocervical gastric-type adenocarcinoma (GAS) is one of the most aggressive subtypes of cervical cancer and is frequently underdiagnosed due to morphological ambiguity, leading to delayed diagnosis. Despite the availability of molecular and genomic assays, their high cost, complexity, and limited reproducibility restrict clinical use. This study therefore proposes a highly sensitive artificial intelligence (AI)-assisted diagnostic system for GAS based exclusively on H&E-stained histopathological images. We incl…

Health

Artificial intelligence-enabled causal estimate of Medicare drug plan integration in cancer care: A doubly robust machine learning instrumental variable analysis

Background Artificial intelligence (AI) methods are increasingly used to strengthen policy evaluation in managed care pharmacy. Among Medicare beneficiaries with cancer, which is one of the most clinically complex and costly populations, prescription drug coverage is obtained through either integrated Medicare Advantage Prescription Drug plans (MA-PDs) or stand-alone Prescription Drug Plans (PDPs). However, causal evidence of plans' impact remains limited because of nonrandom enrollment. Objective To apply an AI…

Health

An informatics framework to harmonize electronic health record medication data for managed care analytics and artificial intelligence applications

Background Artificial intelligence (AI) applications in managed care pharmacy depend on semantically consistent medication data, yet heterogeneous medication identifiers across real-world electronic health records (EHRs) could undermine analytic fidelity and risk propagating classification errors. To enable transportable, reproducible AI tools, methods for harmonizing disparate medication identifiers (eg, National Drug Code [NDC] and Multum drug synonym ID) to standardized vocabularies are required. Objective To…

Health

A pharmacist-overseen, artificial intelligence-enabled model for provider-side prior authorization: From burden to opportunity (PAVE-1)

Prior authorization (PA) imposes substantial administrative burdens on clinicians, contributing to burnout, delayed care, and excess health care spending. Artificial intelligence (AI) is emerging as a tool to automate PA tasks in managed care pharmacy, yet concerns persist regarding transparency, bias, and overreliance on autonomous systems. This is particularly true in payer-deployed AI systems that may deny claims without adequate clinical review. This viewpoint proposes a pharmacist-overseen, AI-enabled syste…